Cargando…

Octocog alfa: Lack of efficacy: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933159/ http://dx.doi.org/10.1007/s40278-022-11901-5

Ejemplares similares

Efficacy of Octocog Alfa (Advate) in a Child with Type 3 von Willebrand Disease and Alloantibodies
por: Sottilotta, Gianluca, et al.
Publicado: (2017)

Pharmacokinetics of recombinant factor VIII in adults with severe hemophilia A: fixed-sequence single-dose study of octocog alfa, rurioctocog alfa pegol, and efanesoctocog alfa
por: Lissitchkov, Toshko, et al.
Publicado: (2023)

Efficacy and safety in patients with haemophilia A switching to octocog alfa (BAY 81–8973): Final results of the global real‐world study, TAURUS
por: Santoro, Cristina, et al.
Publicado: (2022)

External qualification of the Web‐Accessible Population Pharmacokinetic Service–Hemophilia (WAPPS‐Hemo) models for octocog alfa using real patient data
por: Chelle, Pierre, et al.
Publicado: (2021)

Switching from Sucrose-Formulated rFVIII to Octocog Alfa (BAY 81-8973) Prophylaxis Improves Bleed Outcomes in the LEOPOLD Clinical Trials
por: Kenet, Gili, et al.
Publicado: (2023)

Real-World Clinical Outcomes and Replacement Factor VIII Consumption in Patients with Haemophilia A in Italy: A Comparison between Prophylaxis Pre and Post Octocog Alfa (BAY 81-8973)
por: Cortesi, Paolo Angelo, et al.
Publicado: (2022)

Heparin: Lack of efficacy: case report
Publicado: (2022)

Heparin: Lack of efficacy : case report
Publicado: (2022)

Heparin: Lack of efficacy: case report
Publicado: (2022)

Methotrexate: Lack of efficacy: case report
Publicado: (2022)

Heparin: Lack of efficacy: case report
Publicado: (2022)

Acenocoumarol: Lack of efficacy: case report
Publicado: (2022)

Anidulafungin: Lack of efficacy: case report
Publicado: (2022)

Anticoagulants: Lack of efficacy: case report
Publicado: (2022)

Thrombin: Lack of efficacy: case report
Publicado: (2022)

Tozinameran: Lack of efficacy: case report
Publicado: (2022)

Heparin: Lack of efficacy: case report
Publicado: (2022)

Lorazepam: Lack of efficacy: case report
Publicado: (2022)

Elasomeran: Lack of efficacy: case report
Publicado: (2022)

Ravulizumab: Lack of efficacy: case report
Publicado: (2022)

Paracetamol: Lack of efficacy: case report
Publicado: (2022)

Teriflunomide: Lack of efficacy: case report
Publicado: (2022)

Plasma: Lack of efficacy: case report
Publicado: (2022)

Norepinephrine: Lack of efficacy: case report
Publicado: (2022)

Gammaglobulin: Lack of efficacy: case report
Publicado: (2022)

Antipsoriatics: Lack of efficacy: case report
Publicado: (2022)

Tozinameran: Lack of efficacy: case report
Publicado: (2022)

Heparin: Lack of efficacy: case report
Publicado: (2022)

Insulin: Lack of efficacy: case report
Publicado: (2022)

Methylprednisolone: Lack of efficacy: case report
Publicado: (2022)

Apixaban: Lack of efficacy: case report
Publicado: (2022)

Epinephrine: Lack of efficacy: case report
Publicado: (2022)

Clonazepam: Lack of efficacy: case report
Publicado: (2022)

Fluconazole: Lack of efficacy: case report
Publicado: (2022)

Antineoplastics: Lack of efficacy: case report
Publicado: (2022)

Posaconazole: Lack of efficacy: case report
Publicado: (2022)

Antibacterials: Lack of efficacy: case report
Publicado: (2022)

Remdesivir: Lack of efficacy: case report
Publicado: (2022)

Furosemide: Lack of efficacy: case report
Publicado: (2022)

Ceftriaxone: Lack of efficacy: case report
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7t36g244ornhkqjb0ht9hgan5m